应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06609 心玮医疗-B
耶稣受难节休市 03-28 16:08:03
19.400
+0.400
+2.11%
最高
19.500
最低
18.580
成交量
11.40万
今开
18.720
昨收
19.000
日振幅
4.84%
总市值
7.53亿
流通市值
6.12亿
总股本
3,883万
成交额
216.07万
换手率
0.36%
流通股本
3,157万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
心玮医疗-B(06609)发布2023年度业绩 收益2.32亿元 同比增加26.9%
智通财经 · 03-28 17:18
心玮医疗-B(06609)发布2023年度业绩 收益2.32亿元 同比增加26.9%
《公司业绩》心玮医疗-B(06609.HK)全年亏损收窄至9,401.2万元人民币
阿斯达克财经 · 03-28 16:54
《公司业绩》心玮医疗-B(06609.HK)全年亏损收窄至9,401.2万元人民币
心玮医疗-B(06609)股价下跌5.7%,现价港币$18.86
阿斯达克财经 · 03-20
心玮医疗-B(06609)股价下跌5.7%,现价港币$18.86
心玮医疗-B(06609)下跌5.0%,报19.0元/股
金融界 · 03-20
心玮医疗-B(06609)下跌5.0%,报19.0元/股
心玮医疗-B(06609.HK)拟3月28日举行董事会会议批准全年业绩
格隆汇资讯 · 03-18
心玮医疗-B(06609.HK)拟3月28日举行董事会会议批准全年业绩
心玮医疗-B(06609)股价下跌5.687%,现价港币$19.9
阿斯达克财经 · 03-15
心玮医疗-B(06609)股价下跌5.687%,现价港币$19.9
心玮医疗-B(06609)股价上升6.41%,现价港币$20.75
阿斯达克财经 · 03-11
心玮医疗-B(06609)股价上升6.41%,现价港币$20.75
心玮医疗-B(06609)股价上升5.405%,现价港币$19.5
阿斯达克财经 · 03-06
心玮医疗-B(06609)股价上升5.405%,现价港币$19.5
心玮医疗-B(06609)股价下跌7.071%,现价港币$18.4
阿斯达克财经 · 03-01
心玮医疗-B(06609)股价下跌7.071%,现价港币$18.4
心玮医疗-B(06609)股价下跌5.134%,现价港币$19.4
阿斯达克财经 · 02-19
心玮医疗-B(06609)股价下跌5.134%,现价港币$19.4
家临江:脑机接口 港股不认可的风口
智通财经 · 01-31
家临江:脑机接口 港股不认可的风口
港股概念追踪 | 脑机接口迎来“里程碑时刻” 马斯克官宣:人类首次植入脑机接口芯片(附概念股)
智通财经 · 01-30
港股概念追踪 | 脑机接口迎来“里程碑时刻” 马斯克官宣:人类首次植入脑机接口芯片(附概念股)
心玮医疗-B(06609)下跌9.88%,报18.7元/股
金融界 · 01-24
心玮医疗-B(06609)下跌9.88%,报18.7元/股
心玮医疗-B(06609)下跌11.26%,报26.4元/股
金融界 · 01-02
心玮医疗-B(06609)下跌11.26%,报26.4元/股
心玮医疗-B拟900万元出售神玑医疗全部股权
新浪港股 · 2023-12-12
心玮医疗-B拟900万元出售神玑医疗全部股权
心玮医疗-B(06609)拟900万元出售神玑医疗全部股权
智通财经 · 2023-12-11
心玮医疗-B(06609)拟900万元出售神玑医疗全部股权
心玮医疗-B(06609):薛宗玉获选举为监事会主席
智通财经网 · 2023-11-17
心玮医疗-B(06609):薛宗玉获选举为监事会主席
心玮医疗-B(06609):王国辉获选为董事长
智通财经 · 2023-11-08
心玮医疗-B(06609):王国辉获选为董事长
智通港股投资日志|11月8日
智通财经 · 2023-11-08
智通港股投资日志|11月8日
心玮医疗-B(06609):延长关于A股发行的决议案及关于A股发行的授权的有效期
智通财经 · 2023-10-16
心玮医疗-B(06609):延长关于A股发行的决议案及关于A股发行的授权的有效期
加载更多
公司概况
公司名称:
心玮医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
上海心玮医疗科技股份有限公司是从事创新型神经介入医疗器械研发的中国公司。该公司产品组合包括神经介入及心脏医疗器械,其主要产品为Captor取栓器械(Captor)及左心耳封堵器。该公司产品组合从治疗及预防缺血性脑卒中(包括急性缺血性脑卒中及颅内动脉狭窄)到出血性脑卒中的治疗。该公司其他产品包括封堵球囊导管、ExtraFlexTM远端通路导管及SupSelekTM微导管。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06609","market":"HK","secType":"STK","nameCN":"心玮医疗-B","latestPrice":19.4,"timestamp":1711613283021,"preClose":19,"halted":0,"volume":113950,"delay":0,"floatShares":31565804,"shares":38834408,"eps":-5.6420074,"marketStatus":"耶稣受难节休市","marketStatusCode":7,"change":0.4,"latestTime":"03-28 16:08:03","open":18.72,"high":19.5,"low":18.58,"amount":2160690,"amplitude":0.048421,"askPrice":19.5,"askSize":100,"bidPrice":19.32,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-5.2906902513557705,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1712021400000},"adr":0,"listingDate":1629388800000,"adjPreClose":19,"openAndCloseTimeList":[[1711589400000,1711598400000],[1711602000000,1711612800000]],"volumeRatio":0.6585563201320072,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06609","defaultTab":"news","newsList":[{"id":"2422215196","title":"心玮医疗-B(06609)发布2023年度业绩 收益2.32亿元 同比增加26.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422215196","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422215196?lang=zh_cn&edition=full","pubTime":"2024-03-28 17:18","pubTimestamp":1711617516,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心玮医疗-B 发布截至2023年12月31日止年度业绩,该集团期内取得收益2.32亿元,同比增加26.9%;母公司拥有人应占亏损9401.2万元,同比收窄53.08%;每股基本亏损2.47元。取栓支架及抽吸导管,扩张球囊及栓塞保护系统,以及弹簧圈等神经介入治疗类器械贡献了42.3%的销售收入,收入金额同比增长62.9%至9820万元;神经介入通路器械及其他产品同比增长9.3%至1.34亿元。公司研发成本为1.24亿元,用于支持神经介入治疗类器械的多元化在研项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094745.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422315901","title":"《公司业绩》心玮医疗-B(06609.HK)全年亏损收窄至9,401.2万元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2422315901","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422315901?lang=zh_cn&edition=full","pubTime":"2024-03-28 16:54","pubTimestamp":1711616040,"startTime":"0","endTime":"0","summary":"心玮医疗-B(06609.HK) 公布截至去年12月底止全年业绩,营业额2.32亿元人民币(下同),按年升26.9%。亏损收窄至9,401.2万元,上年同期蚀2亿元;每股亏损2.47元。不派息。(js/k)过往派息公布日期派息事项派息内容2023/08/31中期业绩无派息2023/03/20末期业绩无派息 2022/08/31中期业绩无派息 2022/03/28末期业绩无派息 (港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20221005173640251_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20221005173640251_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1338530/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2420056752","title":"心玮医疗-B(06609)股价下跌5.7%,现价港币$18.86","url":"https://stock-news.laohu8.com/highlight/detail?id=2420056752","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2420056752?lang=zh_cn&edition=full","pubTime":"2024-03-20 11:35","pubTimestamp":1710905700,"startTime":"0","endTime":"0","summary":"[下跌股]心玮医疗-B(06609) 股价在上午11:35比前收市价下跌5.7%,现股价为港币$18.86。至目前为止,今日最高价为$21.0,而最低价为$18.86。总成交量为7.855万股,总成交金额为港币$154.923万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133905145_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240320891/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2420751652","title":"心玮医疗-B(06609)下跌5.0%,报19.0元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2420751652","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2420751652?lang=zh_cn&edition=full","pubTime":"2024-03-20 11:01","pubTimestamp":1710903678,"startTime":"0","endTime":"0","summary":"3月20日,心玮医疗-B(06609)盘中下跌5.0%,截至11:01,报19.0元/股,成交117.25万元。心玮医疗是中国的神经介入医疗器械先行者,主要致力于研发和生产神经介入器械,以降低脑卒中的死亡率并改善预后。目前,公司已获批神经介入器械品种7项,包括国产首个获NMPA批准的全套取栓器械和全球首个用于神经介入的颅内雷帕霉素药物洗脱球囊。截至2023年中报,心玮医疗-B营业总收入1.1亿元、净利润-5433.8万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/20110139916818.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2420944747","title":"心玮医疗-B(06609.HK)拟3月28日举行董事会会议批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2420944747","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2420944747?lang=zh_cn&edition=full","pubTime":"2024-03-18 17:02","pubTimestamp":1710752547,"startTime":"0","endTime":"0","summary":"格隆汇3月18日丨心玮医疗-B(06609.HK)宣布,公司将于2024年3月28日(星期四)举行董事会会议,藉以审阅及批准公司及其附属公司截至2023年12月31日止年度的全年业绩及其发布,考虑建议派发末期股息(如有),及处理任何其他业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403181702338b427018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403181702338b427018&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419099905","title":"心玮医疗-B(06609)股价下跌5.687%,现价港币$19.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2419099905","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2419099905?lang=zh_cn&edition=full","pubTime":"2024-03-15 11:09","pubTimestamp":1710472140,"startTime":"0","endTime":"0","summary":"[下跌股]心玮医疗-B(06609) 股价在上午11:09比前收市价下跌5.687%,现股价为港币$19.9。至目前为止,今日最高价为$22.0,而最低价为$19.9。总成交量为2.61万股,总成交金额为港币$55.142万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403152281/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2418738492","title":"心玮医疗-B(06609)股价上升6.41%,现价港币$20.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2418738492","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2418738492?lang=zh_cn&edition=full","pubTime":"2024-03-11 15:54","pubTimestamp":1710143640,"startTime":"0","endTime":"0","summary":"[上升股]心玮医疗-B(06609) 股价在下午03:54比前收市价上升6.41%,现股价为港币$20.75。至目前为止,今日最高价为$20.75,而最低价为$19.7。总成交量为1.375万股,总成交金额为港币$27.464万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403113343/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2417925395","title":"心玮医疗-B(06609)股价上升5.405%,现价港币$19.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2417925395","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2417925395?lang=zh_cn&edition=full","pubTime":"2024-03-06 15:59","pubTimestamp":1709711940,"startTime":"0","endTime":"0","summary":"[上升股]心玮医疗-B(06609) 股价在下午03:59比前收市价上升5.405%,现股价为港币$19.5。至目前为止,今日最高价为$19.5,而最低价为$18.08。总成交量为5100股,总成交金额为港币$9.43万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403065063/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2416166408","title":"心玮医疗-B(06609)股价下跌7.071%,现价港币$18.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2416166408","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2416166408?lang=zh_cn&edition=full","pubTime":"2024-03-01 15:33","pubTimestamp":1709278380,"startTime":"0","endTime":"0","summary":"[下跌股]心玮医疗-B(06609) 股价在下午03:33比前收市价下跌7.071%,现股价为港币$18.4。至目前为止,今日最高价为$20.0,而最低价为$18.4。总成交量为3650股,总成交金额为港币$7.225万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403011998/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2412197509","title":"心玮医疗-B(06609)股价下跌5.134%,现价港币$19.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2412197509","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2412197509?lang=zh_cn&edition=full","pubTime":"2024-02-19 13:00","pubTimestamp":1708318800,"startTime":"0","endTime":"0","summary":"[下跌股]心玮医疗-B(06609) 股价在下午01:00比前收市价下跌5.134%,现股价为港币$19.4。至目前为止,今日最高价为$20.45,而最低价为$19.4。总成交量为1650股,总成交金额为港币$3.287万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2402191540/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2407426483","title":"家临江:脑机接口 港股不认可的风口","url":"https://stock-news.laohu8.com/highlight/detail?id=2407426483","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2407426483?lang=zh_cn&edition=full","pubTime":"2024-01-31 09:23","pubTimestamp":1706664232,"startTime":"0","endTime":"0","summary":"在脑机接口产业链中,Neuralink公司的技术方案最有商业化前景。在2024年1月底,马斯克证实Neuralink已完成第一例人体植入,并且目前状态良好。A股市场“听风便是雨”,在大盘一路下跌中,脑机接口板块普遍逆市大涨,更凸显A股某些资金的大脑需要补充智商。研究机构预计,脑机接口相关市场规模在2030年至2040年期间可达700亿美元至2000亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1065349.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2407629807","title":"港股概念追踪 | 脑机接口迎来“里程碑时刻” 马斯克官宣:人类首次植入脑机接口芯片(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2407629807","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2407629807?lang=zh_cn&edition=full","pubTime":"2024-01-30 15:45","pubTimestamp":1706600757,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,北京时间1月30日,马斯克在社交平台X宣布,昨天首例人类接受了脑机接口公司Neuralink的植入物,目前恢复良好。同年9月,该公司宣布首次进行脑机接口人体实验。此前有报道称,已有数千人正排队等候植入Neuralink的大脑植入设备。Neuralink瞄准的目标疾病包括肢体瘫痪、截瘫、听力损失、大截肢和白内障。业内人士表示,医疗或是未来脑机接口的主要应用领域。据悉,阿里已提交脑机相关专利。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1064190.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2405708458","title":"心玮医疗-B(06609)下跌9.88%,报18.7元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2405708458","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2405708458?lang=zh_cn&edition=full","pubTime":"2024-01-24 10:52","pubTimestamp":1706064721,"startTime":"0","endTime":"0","summary":"1月24日,心玮医疗-B(06609)盘中下跌9.88%,截至10:52,报18.7元/股,成交2829.56万元。心玮医疗是中国的神经介入医疗器械先行者,主要致力于研发和生产神经介入器械,以降低脑卒中的死亡率并改善预后。目前,公司已获批神经介入器械品种7项,包括国产首个获NMPA批准的全套取栓器械和全球首个用于神经介入的颅内雷帕霉素药物洗脱球囊。截至2023年中报,心玮医疗-B营业总收入1.1亿元、净利润-5433.8万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/01/24105239251528.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2400838713","title":"心玮医疗-B(06609)下跌11.26%,报26.4元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2400838713","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2400838713?lang=zh_cn&edition=full","pubTime":"2024-01-02 13:52","pubTimestamp":1704174734,"startTime":"0","endTime":"0","summary":"1月2日,心玮医疗-B(06609)盘中下跌11.26%,截至13:52,报26.4元/股,成交102.08万元。心玮医疗是中国的神经介入医疗器械先行者,主要致力于研发和生产神经介入器械,以降低脑卒中的死亡率并改善预后。目前,公司已获批神经介入器械品种7项,包括国产首个获NMPA批准的全套取栓器械和全球首个用于神经介入的颅内雷帕霉素药物洗脱球囊。截至2023年中报,心玮医疗-B营业总收入1.1亿元、净利润-5433.8万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/01/02135238946037.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2390394094","title":"心玮医疗-B拟900万元出售神玑医疗全部股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2390394094","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2390394094?lang=zh_cn&edition=full","pubTime":"2023-12-12 08:54","pubTimestamp":1702342468,"startTime":"0","endTime":"0","summary":"心玮医疗-B发布公告,于2023年12月11日,公司与买方邢庭瑀、李蒙、神玑雇员持股平台及 Value Magnet Limited订立股权转让协议,据此,公司有条件同意向买方出售其于神玑医疗的全部股权,总代价为人民币900万元。 神玑医疗为一间于中国注册成立的有限公司及公司的全资附属公司。该公司主要专注于依靠电脑辅助技术的医疗器材研发。交割后,公司将不再于神玑医疗拥有任何权益,且该公司将不再为公司的附属公司。股市回暖,抄底炒股先开户!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-12/doc-imzxthfy6574843.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-12/doc-imzxthfy6574843.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2390352926","title":"心玮医疗-B(06609)拟900万元出售神玑医疗全部股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2390352926","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2390352926?lang=zh_cn&edition=full","pubTime":"2023-12-11 22:31","pubTimestamp":1702305107,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心玮医疗-B 发布公告,于2023年12月11日,公司与买方邢庭瑀、李蒙、神玑雇员持股平台及 Value Magnet Limited订立股权转让协议,据此,公司有条件同意向买方出售其于神玑医疗的全部股权,总代价为人民币900万元。因此,董事会认为,在生物科技领域经验丰富的投资者的支持下,透过现有员工以管理层收购的方式出售神玑医疗乃属适当。于交割后,预期神玑医疗将不会与集团竞争。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1036554.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2384597873","title":"心玮医疗-B(06609):薛宗玉获选举为监事会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2384597873","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2384597873?lang=zh_cn&edition=full","pubTime":"2023-11-17 20:33","pubTimestamp":1700224417,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心玮医疗-B(06609)发布公告,于2023年11月17日举行的公司监事会大会上,薛宗玉先生已获选举为监事会主席,其任期自2023年11月17日至第二届监事会任期届满之日止,即时生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231117203515842269f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231117203515842269f8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2381288414","title":"心玮医疗-B(06609):王国辉获选为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2381288414","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2381288414?lang=zh_cn&edition=full","pubTime":"2023-11-08 22:25","pubTimestamp":1699453542,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心玮医疗-B 发布公告,经股东于临时股东大会上批准,董事会欣然宣布王国辉先生、张坤女士及韦家威先生获重选为执行董事;丁魁先生及陈少雄先生获重选为非执行董事;以及陈刚先生获推选为非执行董事;及郭少牧先生、冯向前先生及龚平先生获重选为独立非执行董事。紧随临时股东大会后,王国辉先生获一致推选为第二届董事会的董事长,任期与彼担任董事的任期一致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1021832.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2381490983","title":"智通港股投资日志|11月8日","url":"https://stock-news.laohu8.com/highlight/detail?id=2381490983","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2381490983?lang=zh_cn&edition=full","pubTime":"2023-11-08 00:00","pubTimestamp":1699372802,"startTime":"0","endTime":"0","summary":"智通财经APP统计,2023年11月8日,港股上市公司投资日志如下: 类别 公司 新股活动药明合联(招股中) 业绩公布日贝壳-W环球数码创意雅居投资控股骏杰集团控股邝文记富银融资股份创辉珠宝HM INTL HLDGS仁德资源荧德控股 股东大会召开日大陆航空科技控股红星美凯龙潍柴动力纵横游控股南顺(香港)奇点国际大明国际心玮医疗-BMAYER HOLDINGS 分红派息卓越商企服务(除净日)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1021273.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2375311216","title":"心玮医疗-B(06609):延长关于A股发行的决议案及关于A股发行的授权的有效期","url":"https://stock-news.laohu8.com/highlight/detail?id=2375311216","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2375311216?lang=zh_cn&edition=full","pubTime":"2023-10-16 22:01","pubTimestamp":1697464879,"startTime":"0","endTime":"0","summary":"截至本公告日期,鉴于A股发行仍在进行中,且关于A股发行的决议案及关于A股发行的授权之有效期将于2023年11月8日到期,经考虑注册及A股发行的目前进度,建议将关于A股发行的决议案及关于A股发行的授权之有效期延长12个月属合理。董事会建议将关于A股发行的决议案及关于A股发行的授权之有效期自于即将召开的股东大会、H股类别股东大会及非上市股份类别股东大会上获审议批准之日起延长12个月,以确保A股发行的持续进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1006910.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.strokemedical.com","stockEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":-0.0348},{"period":"3month","weight":-0.3479},{"period":"6month","weight":-0.1849},{"period":"1year","weight":-0.4699},{"period":"ytd","weight":-0.3479}],"compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0149},{"period":"3month","weight":-0.0297},{"period":"6month","weight":-0.0712},{"period":"1year","weight":-0.1808},{"period":"ytd","weight":-0.0297}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海心玮医疗科技股份有限公司是从事创新型神经介入医疗器械研发的中国公司。该公司产品组合包括神经介入及心脏医疗器械,其主要产品为Captor取栓器械(Captor)及左心耳封堵器。该公司产品组合从治疗及预防缺血性脑卒中(包括急性缺血性脑卒中及颅内动脉狭窄)到出血性脑卒中的治疗。该公司其他产品包括封堵球囊导管、ExtraFlexTM远端通路导管及SupSelekTM微导管。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"心玮医疗-B","nameEN":"HEARTCARE-B"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心玮医疗-B,06609,心玮医疗-B股票,心玮医疗-B股票老虎,心玮医疗-B股票老虎国际,心玮医疗-B行情,心玮医疗-B股票行情,心玮医疗-B股价,心玮医疗-B股市,心玮医疗-B股票价格,心玮医疗-B股票交易,心玮医疗-B股票购买,心玮医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}